[1] |
刘涵,沈强,张蓝月,等.糖尿病视网膜病变分子生物标志物的研究进展[J/OL].中华眼科医学杂志(电子版),2023,13(6):376-380.
|
[2] |
Hachana S,Larrivée B.TGF-βsuperfamily signaling in the eye:implications for ocular pathologies[J].Cells,2022,11(15):2336.
|
[3] |
MassaguéJ,Sheppard D.TGF-βsignaling in health and disease[J].Cell,2023,186(19):4007-4037.
|
[4] |
Nickel J,Ten Dijke P,Mueller TD.TGF-βfamily co-receptor function and signaling[J].Acta Biochim Biophys Sin(Shanghai),2018,50(1):12-36.
|
[5] |
Callan A,Jha S,Valdez L,et al.TGF-βsignaling pathways in the development of diabetic retinopathy[J].Int JMol Sci,2024,25(5):3052.
|
[6] |
Shu DY,Lovicu FJ.Insights into bone morphogenetic protein-(BMP-)Signaling in ocular lens biology and pathology[J].Cells,2021,10(10):2604.
|
[7] |
Desroches-Castan A,Tillet E,Bouvard C,et al.BMP9 and BMP10:two close vascular quiescence partners that stand out[J].Dev Dyn,2022,251(1):178-197.
|
[8] |
Bielmeier CB,Schmitt SI,Kleefeldt N,et al.Deficiency in retinal TGFβ signaling aggravates neurodegeneration by modulating pro-apoptotic and MAPkinase pathways[J].Int JMol Sci,2022,23(5):2626.
|
[9] |
Ogata FT,Verma S,Coulson-Thomas VJ,et al.TGF-β-Based therapies for treating ocular surface disorders[J].Cells,2024,13(13):1105.
|
[10] |
Wang Y,Yang X,Li Q,et al.Single-cell RNA sequencing reveals the müller subtypes and inner blood-retinal barrier regulatory network in early diabetic retinopathy[J].Front Mol Neurosci,2022,15:1048634.
|
[11] |
Perisset S,Potilinski MC,Gallo JE.Role of Lnc-RNAs in the pathogenesis and development of diabetic retinopathy[J].Int J Mol Sci,2023,24(18):13947.
|
[12] |
Schlecht A,Vallon M,Wagner N,et al.TGFβ-Neurotrophin interactions in heart,retina,and brain[J].Biomolecules,2021,11(9):1360.
|
[13] |
黎晓冬,李志林,武海燕,等.TGF-β在增殖性视网膜疾病中的研究进展[J].国际眼科杂志,2022,22(12):1977-1981.
|
[14] |
Wang M,Sheng KJ,Fang JC,et al.Redox signaling in diabetic retinopathy and opportunity for therapeutic intervention through natural products[J].Eur J Med Chem,2022,244:114829.
|
[15] |
Bonfiglio V,Platania CBM,Lazzara F,et al.TGF-β serum levels in diabetic retinopathy patients and the role of anti-VEGF therapy[J].Int J Mol Sci,2020,21(24):9558.
|
[16] |
王娟,储辉.糖尿病视网膜病变患者TGF-β1、TGF-β2水平及临床意义[J].中国医药导报,2021,18(18):123-126.
|
[17] |
Saucedo L,Pfister IB,Zandi S,et al.Ocular TGF-β,matrix metalloproteinases,and TIMP-1 increase with the development and progression of diabetic retinopathy in type 2 diabetes mellitus[J].Mediators Inflamm,2021,PMID:9811361.
|
[18] |
Song S,Yu X,Zhang P,et al.Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy[J].J Diabetes Complications, 2020, 34(9):107641.
|
[19] |
丁玉龙.房水中TGF-β1、VEGF水平与糖尿病性白内障患者术后黄斑水肿发生的关系[J].医药论坛杂志,2021,42(18):114-117.
|
[20] |
杨洁,朱晓敏,胡子毅,等.糖尿病视网膜病变患者血清转化生长因子-β水平变化及其在监测抗VEGF药物治疗效果中的作用[J].眼科新进展,2021,41(12):1158-1163.
|
[21] |
Al-Shabrawey M, Hussein K, Wang F, et al.Bone morphogenetic protein-2 induces non-canonical inflammatory and oxidative pathways in human retinal endothelial cells[J].Front Immunol,2021,11:568795.
|
[22] |
Elmasry K,Habib S,Moustafa M,et al.Bone morphogenetic proteins and diabetic retinopathy[J].Biomolecules,2021,11(4):593.
|
[23] |
Darwish NHE, Hussein KA, Elmasry K, et al.Bone morphogenetic protein-4 impairs retinal endothelial cell barrier,a potential role in diabetic retinopathy[J].Cells,2023,12(9):1279.
|
[24] |
Dong L,Zhang Z,Liu X,et al.RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy[J].JMol Med(Berl),2021,99(2):225-240.
|
[25] |
刘涵,方晏红,张蓝月,等.血脂异常与糖尿病视网膜病变的相关性研究进展[J/OL].中华眼科医学杂志(电子版),2023,13(5):301-305.
|
[26] |
Wu L,Li J,Zhao F,et al.MiR-340-5p inhibits Müller cell activation and pro-inflammatory cytokine production by targeting BMP4 in experimental diabetic retinopathy[J].Cytokine,2022,149:155745.
|
[27] |
Niu Y,Zhang W,Shi J,et al.The relationship between circulating growth differentiation factor 15 levels and diabetic retinopathy in patients with type2 diabetes[J].Front Endocrinol(Lausanne),2021,12:627395.
|
[28] |
Chung JO,Park SY,Cho DH,et al.Relationship between plasma growth differentiation factor-15 levels and diabetic retinopathy in individuals with type 2 diabetes[J].Sci Rep,2020,10(1):20568.
|
[29] |
Chen HY,Ho YJ,Chou HC,et al.The Role of transforming growth factor-beta in retinal ganglion cells with hyperglycemia and oxidative stress[J].Int J Mol Sci,2020,21(18):6482.
|
[30] |
Chen H,Zhang X,Liao N,et al.Identification of NLRP3 inflammation-related gene promoter hypomethylation in diabetic retinopathy[J].Invest Ophthalmol Vis Sci,2020,61(13):12.
|
[31] |
Costa AR,Dieter C,Canani LH,et al.The rs1800469 T/T and rs1800470 C/C genotypes of the TGFB1 gene confer protection against diabetic retinopathy in a southern Brazilian population[J].Genet Mol Biol,2023,46(3):e20220247.
|
[32] |
Gong Y,Li X,Xie L.Circ_0001897 regulates high glucoseinduced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-29c-3p/transforming growth factor beta 2 axis[J].Bioengineered,2022,13(5):11694-11705.
|
[33] |
Xue L,Xiong C,Li J,et al.MiR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway[J].Biosci Rep,2020,40(11):BSR20201545.
|
[34] |
Shao K,Xi L,Cang Z,et al.Knockdown of NEAT1 exerts suppressive effects on diabetic retinopathy progression via inactivating TGF-β1 and VEGF signaling pathways[J].J Cell Physiol,2020,235(12):9361-9369.
|
[35] |
张达宁,冷瀛,秦海翔,等.视网膜色素上皮细胞LncRNA MEG3在不同葡萄糖浓度下的表达情况及对VEGF和TGFβ1表达的影响[J].眼科新进展,2022,42(7):524-528.
|
[36] |
Trotta MC,Petrillo F,Gesualdo C,et al.Effects of the Calix[4]arene derivative compound OTX008 on high glucose-stimulated ARPE-19 cells:focus on galectin-1/TGF-β/EMT pathway[J].Molecules,2022,27(15):4785.
|
[37] |
Rodriguez R,Lowe K,Keniry M,et al.Involvement of TGFβ signaling pathway in oxidative stress and diabetic retinopathy[J].Arch Clin Exp Ophthalmol,2021,3(2):23-28.
|
[38] |
Sun P,Xu N,Li Y,et al.Destruction of the blood-retina barrier in diabetic retinopathy depends on angiotensin-converting enzymemediated TGF-β1/Smad signaling pathway activation[J].Int Immunopharmacol,2020,85:106686.
|
[39] |
Han T,Li W,Zhang H,et al.Involvement of long non-coding RNA ZNF503 antisense RNA 1 in diabetic retinopathy and its possible underlying mechanism[J].Bioengineered,2022,13(6):14057-14065.
|
[40] |
Hsiao CC,Chang YC,Hsiao YT,et al.Triamcinolone acetonide modulates TGF-β2-induced angiogenic and tissue-remodeling effects in cultured human retinal pigment epithelial cells[J].Mol Med Rep,2021,24(5):802.
|
[41] |
Zhou J, Xie Z.Endostatin inhibits blood-retinal barrier breakdown in diabetic rats by increasing the expression of ICAM-1 and VCAM-1 and decreasing the expression of VEGF[J].Comput Math Methods Med,2022,PMID:5105866.
|
[42] |
周婧,韩梅.非奈利酮通过抑制小胶质细胞炎症反应减轻大鼠糖尿病视网膜病变[J].中国病理生理杂志,2023,39(8):1483-1490.
|
[43] |
Fan J,Shen W,Lee SR,et al.Targeting the Notch and TGF-β signaling pathways to prevent retinal fibrosis in vitro and in vivo[J].Theranostics,2020,10(18):7956-7973.
|
[44] |
Mei W,Zhu B, Shu Y, et al.GDF11 protects against glucotoxicity-induced mice retinal microvascular endothelial cell dysfunction and diabetic retinopathy disease[J].Mol Cell Endocrinol,2021,537:111422.
|
[45] |
Li RL,Wang JX,Chai LJ,et al.Xueshuantong for injection(Lyophilized) alleviates streptozotocin-induced diabetic retinopathy in rats[J].Chin JIntegr Med,2020,26(11):825-832.
|
[46] |
蒲洁琨,姜爱雯,冯筱巍,等.基于miR-29b/TGF-β/Smad信号通路探讨复方血栓通对糖尿病视网膜病变大鼠作用的机制分析[J].临床和实验医学杂志,2024,23(11):1121-1125.
|
[47] |
邓锦满,胡润凯,韩伟超,等.黄芪甲苷联合西格列汀对糖尿病大鼠糖脂代谢、氧化应激及TGF-β1/PI3K/Akt信号通路的影响[J].中国老年学杂志,2022,42(18):4522-4526.
|
[48] |
陈志义,邱庆华,姚宜.元芪祛瘀方对增殖型糖尿病视网膜病变的疗效及血清CMKLR1、TGF-β1及CTGF的影响[J].四川中医,2022,40(1):160-164.
|
[49] |
史强,王顺彩.七叶皂苷钠片对糖尿病视网膜病变合并黄斑水肿患者的临床疗效[J].中成药,2023,45(7):2197-2201.
|
[50] |
艾华.补阳还五汤合六君子汤加减治疗糖尿病视网膜病变40例[J].环球中医药,2018,11(10):1614-1617.
|
[51] |
吕亚男,顾青,李东丽,等.叶黄素对转化生长因子-β2诱导的视网膜色素上皮细胞上皮-间质转化的影响[J].上海交通大学学报(医学版),2019,39(6):572-577,571.
|
[52] |
Bhattamisra SK,Koh HM,Lim SY,et al.Molecular and biochemical pathways of catalpol in alleviating diabetes mellitus and its complications[J].Biomolecules,2021,11(2):323.
|